Sunshine Biopharma Inc. (SBFM) - Form 8-K Summary
Business Context and Reporting Period
Sunshine Biopharma Inc., a Colorado corporation headquartered in Fort Lauderdale, Florida, filed this Current Report on Form 8-K on November 7, 2024, regarding events occurring on November 6, 2024. The filing serves to announce the Company's financial results for the period ended September 30, 2024. The Company's common stock (SBFM) and warrants (SBFMW) trade on The Nasdaq Stock Market LLC.
Financial Metrics
This Form 8-K is a notification of results and does not contain specific financial data points within the text provided. The filing references a press release (Exhibit 99.1) for detailed figures. Consequently, specific values for revenue, profit, cash flow, margins, debt, and liquidity are not present in this document. The filing text does not provide a clear value for these metrics.
Material Changes
The filing does not detail specific material changes versus prior periods. It solely indicates that financial results for the quarter ended September 30, 2024, have been issued. Investors must refer to the attached press release to assess year-over-year or quarter-over-quarter performance.
Guidance, Outlook, and Risks
The document contains no management commentary, forward-looking guidance, or specific risk factors. It includes a standard disclaimer stating that the information in Item 2.02 and Exhibit 99.1 is not deemed "filed" for purposes of Section 18 of the Exchange Act and will not be incorporated by reference into other filings unless expressly stated.
Key Facts for Investor Verification
- Verify the specific financial results (revenue, net loss, cash position) by reviewing the attached Press Release (Exhibit 99.1), as this 8-K text contains no numerical data.
- Confirm the trading status of Common Stock (SBFM) and Warrants (SBFMW) on Nasdaq.
- Note that the financial results cover the period ended September 30, 2024.
- Be aware that the press release content is not automatically incorporated by reference into other SEC filings.